Amylyx Pharmaceuticals, Inc. AMLX Return on invested capital

Return on invested capital at other companies

MBX Biosciences, Inc.MBX

-33%—

Viking TherapeuticsVKTX

-59.2%-292pp

Crinetics PharmaceuticalsCRNX

-45.1%+1.9pp

VAN

Vivani MedicalVANI

-151.1%+81.7pp

uniQureQURE

-119%+424pp

MeiraGTx Holdings plcMGTX

-265.7%-18.2pp

FAQ

What is Amylyx Pharmaceuticals, Inc.'s return on invested capital?

Amylyx Pharmaceuticals, Inc. (AMLX) reported return on invested capital of -104.3% in Q2 2026.

How has Amylyx Pharmaceuticals, Inc.'s return on invested capital changed year-over-year?

Amylyx Pharmaceuticals, Inc.'s return on invested capital increased by 19.2% year-over-year, from -129.1% to -104.3%.

What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s return on invested capital?

Over 2 years (2023 to 2025), Amylyx Pharmaceuticals, Inc.'s return on invested capital has grown at a 271.7% compound annual growth rate (CAGR), from 12.8% to -176.3%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.